Theriva Biologics, Inc.

DB:SFY0 Stock Report

Market Cap: €2.7m

Theriva Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SFY0?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders13,2510.583%
Hedge Funds139,0466.12%
Private Companies140,0006.16%
VC/PE Firms180,0007.92%
Institutions352,87415.5%
General Public1,447,29163.7%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 233.3%.

Top Shareholders

Top 25 shareholders own 36.31% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.92%
Heights Capital Management, Inc.
180,000€214.2k0%0.1%
6.25%
Susquehanna International Group, LLP, Asset Management Arm
141,958€168.9k0%no data
6.16%
Intracoastal Capital LLC
140,000€166.6k0%no data
6.12%
Anson Group
139,046€165.5k0%0.02%
4.4%
Armistice Capital LLC
100,000€119.0k0%no data
1.2%
MSD Partners, L.P.
27,316€32.5k14.1%0.02%
0.89%
Morgan Stanley, Investment Banking and Brokerage Investments
20,200€24.0k2,020,000%no data
0.79%
UBS Asset Management AG
17,851€21.2k1,790,000%no data
0.6%
Two Sigma Investments, LP
13,566€16.1k0%no data
0.52%
Hudson River Trading LLC, Asset Management Arm
11,806€14.0k0%no data
0.45%
Two Sigma Securities, LLC, Asset Management Arm
10,120€12.0k315%no data
0.44%
Steven Shallcross
10,000€11.9k0%no data
0.33%
BlackRock, Inc.
7,567€9.0k0%no data
0.14%
Frank Tufaro
3,225€3.8k-0.03%no data
0.038%
Osaic Wealth, Inc. , Asset Management Arm
854€1.0k85,300%no data
0.029%
Tower Research Capital Europe Limited
661€786.713,100%no data
0.022%
Barclays PLC Private Banking & Investment Banking Investment
495€589.00%no data
0.019%
Advisor Group Holdings, Inc., Asset Management Arm
440€523.60%no data
0.0011%
Jeffrey Kraws
26€30.80%no data
0.00062%
Iron Horse Wealth Management, LLC
14€16.80%no data
0.00048%
IFP Advisors, LLC
11€13.00%no data
0.0004%
Bank of America Corporation, Asset Management Arm
9€10.880%no data
0.00018%
Planning Capital Management Corp.
4€4.90%no data
0.00004%
City National Rochdale, LLC
1€1.10%no data
0.00004%
City National Bank, Asset Management Arm
1€1.10%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/11/20 11:57
End of Day Share Price 2024/08/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Theriva Biologics, Inc. is covered by 10 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
Keay NakaeAscendiant Capital Markets LLC
Timothy ChiangBTIG